Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Boston Scientific Enteryx GERD Device Clears FDA With Limited Indication

This article was originally published in The Gray Sheet

Executive Summary

Patients who respond to pharmacological treatments for gastroesophageal reflux disease (GERD) have a new therapeutic alternative in Boston Scientific's Enteryx injectable treatment system

You may also be interested in...



Patient-Reported Outcomes In Device Trials: FDA Guidance Under Review

FDA is reviewing a draft guidance on use of patient-reported outcome data in device evaluations, according to Division of Cardiovascular Devices Medical Officer Neal Muni, MD

Patient-Reported Outcomes In Device Trials: FDA Guidance Under Review

FDA is reviewing a draft guidance on use of patient-reported outcome data in device evaluations, according to Division of Cardiovascular Devices Medical Officer Neal Muni, MD

Boston Scientific Enteryx

Gastroesophageal reflux disease treatment gains newly assigned CPT code, permitting reimbursement under the hospital outpatient prospective payment system in 2004. The liquid polymer earned FDA approval in April (1"The Gray Sheet" April 28, 2003, p. 6)...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018263

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel